Skip to main content
Market intelligence
RLAYHealthcare

Relay Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jul 28, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 28, 2026Thomas CatinazzoChief Financial OfficerSale1,459$18.61$27,152
Jul 28, 2026Peter RahmerSee remarksSale748$18.61$13,920
Jul 28, 2026Donald A BergstromPresident, R&DSale2,237$18.61$41,631